DAVID F. HOFFMEISTER - Corporate Board Profile

Celanese Corp

Filing Date	Source Excerpt
2016-02-17	Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by Fisher Scientific Inc. in February 2014. From October 2004 to November 2008, he served as Chief Financial Officer of Invitrogen Corporation, which merged with Applied Biosystems in November 2008 to form Life Technologies Corporation. Before joining Invitrogen, Mr. Hoffmeister spent 20 years with McKinsey & Company as a senior partner serving clients in the healthcare, private equity and chemical industries on issues of strategy and organization.
2017-03-10	Mr. Hoffmeister served as CFO of Life Technologies Corporation and was a senior partner at McKinsey & Company.
2018-03-09	Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by Fisher Scientific Inc. in February 2014. From October 2004 to November 2008, he served as Chief Financial Officer of Invitrogen Corporation, which merged with Applied Biosystems in November 2008 to form Life Technologies Corporation. Before joining Invitrogen, Mr. Hoffmeister spent 20 years with McKinsey & Company as a senior partner serving clients in the healthcare, private equity and chemical industries on issues of strategy and organization.
2018-08-08	Directors: David F. Hoffmeister
2019-03-08	Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporation... spent 20 years with McKinsey & Company as a senior partner... no mention of software or programming.
2020-03-06	Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporation... He spent 20 years with McKinsey & Company as a senior partner... no mention of software or programming.
2021-03-05	Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by Fisher Scientific Inc. in February 2014. From October 2004 to November 2008, he served as Chief Financial Officer of Invitrogen Corporation, which merged with Applied Biosystems in November 2008 to form Life Technologies Corporation. Before joining Invitrogen, Mr. Hoffmeister spent 20 years with McKinsey & Company as a senior partner serving clients in the healthcare, private equity and chemical industries on issues of strategy and organization.
2022-03-10	Mr. Hoffmeister served as the Senior Vice President and Chief Financial Officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by ThermoFisher Scientific Inc. in February 2014. From October 2004 to November 2008, he served as Chief Financial Officer of Invitrogen Corporation, which merged with Applied Biosystems in November 2008 to form Life Technologies Corporation.
2023-03-09	Senior Vice President and Chief Financial Officer of Life Technologies Corporation; Senior partner at McKinsey & Company; B.A. in business administration and management, University of Minnesota; MBA, University of Chicago Booth School of Business.
2024-03-21	Senior Vice President and Chief Financial Officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by ThermoFisher Scientific Inc. (2008 – 2014)
2025-03-24	David F. Hoffmeister, Former SVP / CFO – Life Technologies Corp., B.A., Business Administration and Management, University of Minnesota, MBA, University of Chicago Booth School of Business.

GLAUKOS Corp

Filing Date	Source Excerpt
2016-04-19	Mr. Hoffmeister served as senior vice president and chief financial officer of Life Technologies Corporation and holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago.
2017-04-18	Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago. He served as senior partner at McKinsey & Company and as CFO of Life Technologies Corporation.
2018-04-18	Mr. Hoffmeister served as the senior vice president and chief financial officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by Thermo Fisher Scientific Inc. in February 2014. Mr. Hoffmeister currently serves on the boards of directors of Celanese Corporation, ICU Medical, Inc. and Kaiser Permanente.
2019-04-17	Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago.
2020-04-24	Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago. We believe Mr. Hoffmeister’s strong finance background, experience as a chief financial officer of a global biotechnology company, and public company board experience qualify him to serve on our Board of Directors.
2021-04-22	Mr. Hoffmeister served as the senior vice president and chief financial officer of Life Technologies Corporation... and spent 20 years with McKinsey & Company as a senior partner.
2022-04-19	Mr. Hoffmeister served as the senior vice president and chief financial officer of Life Technologies Corporation ... Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago.
2023-04-18	Senior Vice President and Chief Financial Officer, Life Technologies Corporation (2008 to 2014); MBA from University of Chicago; no mention of software or technical skills.
2024-04-16	Senior Vice President and Chief Financial Officer, Life Technologies Corporation; Senior Partner, McKinsey & Company; Bachelor of Science, University of Minnesota; MBA, University of Chicago.

Filing Date

Source Excerpt

2016-04-19

Mr. Hoffmeister served as senior vice president and chief financial officer of Life Technologies Corporation and holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago.

2017-04-18

Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago. He served as senior partner at McKinsey & Company and as CFO of Life Technologies Corporation.

2018-04-18

Mr. Hoffmeister served as the senior vice president and chief financial officer of Life Technologies Corporation, a global life sciences company, prior to its acquisition by Thermo Fisher Scientific Inc. in February 2014. Mr. Hoffmeister currently serves on the boards of directors of Celanese Corporation, ICU Medical, Inc. and Kaiser Permanente.

2019-04-17

Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago.

2020-04-24

Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago. We believe Mr. Hoffmeister’s strong finance background, experience as a chief financial officer of a global biotechnology company, and public company board experience qualify him to serve on our Board of Directors.

2021-04-22

Mr. Hoffmeister served as the senior vice president and chief financial officer of Life Technologies Corporation... and spent 20 years with McKinsey & Company as a senior partner.

2022-04-19

Mr. Hoffmeister served as the senior vice president and chief financial officer of Life Technologies Corporation ... Mr. Hoffmeister holds a B.S. from the University of Minnesota and an M.B.A. from the University of Chicago.

2023-04-18

Senior Vice President and Chief Financial Officer, Life Technologies Corporation (2008 to 2014); MBA from University of Chicago; no mention of software or technical skills.

2024-04-16

Senior Vice President and Chief Financial Officer, Life Technologies Corporation; Senior Partner, McKinsey & Company; Bachelor of Science, University of Minnesota; MBA, University of Chicago.

ICU MEDICAL INC/DE

Filing Date	Source Excerpt
2018-04-05	David F. Hoffmeister Mr. Hoffmeister, 63, has been director since January 2018 and serves as a member of the Audit Committee.
2019-04-05	Mr. Hoffmeister, 64, has been director since January 2018 and serves as a member of the Audit Committee and the Compensation Committee.
2020-04-03	David F. Hoffmeister, member of Audit Committee and Compensation Committee, 2019 total compensation $240,014.
2021-04-01	David F. Hoffmeister Mr. Hoffmeister, 66, has been director since January 2018 and serves as a member of the Audit Committee and the Compensation Committee.
2022-04-04	Mr. Hoffmeister, 67, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. Mr. Hoffmeister served as Senior Vice President and Chief Financial Officer of Life Technologies Corp. from 2004 to 2014. Prior to joining Life Technologies, Mr. Hoffmeister was a senior partner with McKinsey & Co., focusing on health care, private equity and chemicals industries. Before joining McKinsey, Mr. Hoffmeister held financial positions at GTE Corp. and W.R. Grace and Co. Mr. Hoffmeister currently serves on the boards of Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals and has since November of 2014. Mr. Hoffmeister currently serves on the Board of Directors of Glaukos Corp. and has since 2014; Celanese Corp., since 2005; and Stepstone Group, Inc. since 2020. Mr. Hoffmeister received a bachelor’s of science degree from University of Minnesota and a M.B.A. from University of Chicago. The Board believes Mr. Hoffmeister should serve as a director due to his strong finance background and extensive experience as a chief financial officer of a global biotechnology company.
2023-04-04	Mr. Hoffmeister, 68, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. ... The Board has determined that directors Messrs. Greenberg, Abbey, and Hoffmeister, Ms. Finney, Ms. Hernandez and Ms. Kennedy qualify as independent under NASDAQ Listing Rules.
2024-04-02	Mr. Hoffmeister, 69, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. ... The Board believes Mr. Hoffmeister should serve as a director due to his strong finance background and extensive experience as a chief financial officer of a global biotechnology company.
2025-04-03	Mr. Hoffmeister, 70, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. ... The Board believes Mr. Hoffmeister should serve as a director due to his strong finance background and extensive experience as a chief financial officer of a global biotechnology company.

Filing Date

Source Excerpt

2018-04-05

David F. Hoffmeister Mr. Hoffmeister, 63, has been director since January 2018 and serves as a member of the Audit Committee.

2019-04-05

Mr. Hoffmeister, 64, has been director since January 2018 and serves as a member of the Audit Committee and the Compensation Committee.

2020-04-03

David F. Hoffmeister, member of Audit Committee and Compensation Committee, 2019 total compensation $240,014.

2021-04-01

David F. Hoffmeister Mr. Hoffmeister, 66, has been director since January 2018 and serves as a member of the Audit Committee and the Compensation Committee.

2022-04-04

Mr. Hoffmeister, 67, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. Mr. Hoffmeister served as Senior Vice President and Chief Financial Officer of Life Technologies Corp. from 2004 to 2014. Prior to joining Life Technologies, Mr. Hoffmeister was a senior partner with McKinsey & Co., focusing on health care, private equity and chemicals industries. Before joining McKinsey, Mr. Hoffmeister held financial positions at GTE Corp. and W.R. Grace and Co. Mr. Hoffmeister currently serves on the boards of Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals and has since November of 2014. Mr. Hoffmeister currently serves on the Board of Directors of Glaukos Corp. and has since 2014; Celanese Corp., since 2005; and Stepstone Group, Inc. since 2020. Mr. Hoffmeister received a bachelor’s of science degree from University of Minnesota and a M.B.A. from University of Chicago. The Board believes Mr. Hoffmeister should serve as a director due to his strong finance background and extensive experience as a chief financial officer of a global biotechnology company.

2023-04-04

Mr. Hoffmeister, 68, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. ... The Board has determined that directors Messrs. Greenberg, Abbey, and Hoffmeister, Ms. Finney, Ms. Hernandez and Ms. Kennedy qualify as independent under NASDAQ Listing Rules.

2024-04-02

Mr. Hoffmeister, 69, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. ... The Board believes Mr. Hoffmeister should serve as a director due to his strong finance background and extensive experience as a chief financial officer of a global biotechnology company.

2025-04-03

Mr. Hoffmeister, 70, has been director since January 2018 and serves as Chair of the Audit Committee and a member of the Compensation Committee. ... The Board believes Mr. Hoffmeister should serve as a director due to his strong finance background and extensive experience as a chief financial officer of a global biotechnology company.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22